

For the first time, patients living with Alzheimer's disease (AD) and their families have options. Yet, the recent approvals and market performance of disease-modifying treatments demonstrate a glaring truth: The healthcare system is unprepared to deliver the hope that these new treatments promise.
In this paper, we tackle what is needed to reach as many patients as possible, diving deep into the alignment that must exist in and between five key areas: advocacy, approval, adoption, access, and adherence. With an intentional focus on each, and the connectivity between them, the all-stakeholder empowerment needed to best serve patients and their families can (and will) be achieved.
New feature: Scroll down to access the audio version of this insight brief!